Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The aim of the study is to investigate the effect of roflumilast (APTA-2217) on lung function in patients with asthma. Roflumilast will be administered orally once daily. The study duration consists of a baseline period (2 to 4 weeks) and a treatment period (24 weeks). The study will provide further data on safety, tolerability, and effectiveness of roflumilast.
Epistemonikos ID: fbffcaaa236bf41cfc4302542822912790888dfe
First added on: May 04, 2024